Brain tumors across the age spectrum: biology, therapy, and late effects.
暂无分享,去创建一个
[1] T. Merchant,et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. , 2009, The Lancet. Oncology.
[2] T. Pietsch,et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. , 2005, The New England journal of medicine.
[3] D. Louis,et al. Adult Medulloblastoma: Prognostic Factors and Patterns of Relapse , 2000, Neurosurgery.
[4] M. Kloor,et al. Microsatellite Instability in Pediatric and Adult High‐grade Gliomas , 2007, Brain pathology.
[5] D. Figarella-Branger,et al. Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases , 2003, Neurosurgery.
[6] M. Gilbert,et al. Ependymomas of the adult: molecular biology and treatment , 2008, Current opinion in neurology.
[7] T. Merchant,et al. Temozolomide after Radiotherapy for Newly Diagnosed High-grade Glioma and Unfavorable Low-grade Glioma in Children , 2006, Journal of Neuro-Oncology.
[8] Axel Benner,et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] T. Merchant. Three-dimensional conformal radiation therapy for ependymoma , 2009, Child's Nervous System.
[10] T. Merchant,et al. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. , 2003, International journal of radiation oncology, biology, physics.
[11] P. Wesseling,et al. Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH , 2002, The Journal of pathology.
[12] P. Lichter,et al. Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma , 2006, Clinical Cancer Research.
[13] O. Chinot,et al. Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. , 2007, Brain : a journal of neurology.
[14] C. Meisner,et al. Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. , 2000, International journal of radiation oncology, biology, physics.
[15] E. Garrett-Mayer,et al. High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomas , 2009, Journal of Neuro-Oncology.
[16] M. Sengoz,et al. Medulloblastoma in adults: treatment results and prognostic factors. , 2002, International journal of radiation oncology, biology, physics.
[17] Jing Ma,et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas , 2009, The Journal of pathology.
[18] M E Cohen,et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. , 1993, The New England journal of medicine.
[19] D. Frappaz,et al. Histopathological grading of intracranial pediatric ependymomas , 2008 .
[20] T. Merchant,et al. Phase II trial of conformal radiation therapy for pediatric low-grade glioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] H. Ng,et al. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas , 2000, Histopathology.
[22] C. Miller,et al. Malignant Gliomas with Primitive Neuroectodermal Tumor‐like Components: A Clinicopathologic and Genetic Study of 53 Cases , 2009, Brain pathology.
[23] R. McLendon,et al. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. , 2008, Archives of pathology & laboratory medicine.
[24] Axel Benner,et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] T. Merchant,et al. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children. , 2002, International journal of radiation oncology, biology, physics.
[26] P. Burger,et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Brandes,et al. The treatment of adults with medulloblastoma: a prospective study. , 2003, International journal of radiation oncology, biology, physics.
[28] T. Merchant,et al. Factors associated with neurological recovery of brainstem function following postoperative conformal radiation therapy for infratentorial ependymoma. , 2010, International journal of radiation oncology, biology, physics.
[29] E. Holland,et al. Modeling Adult Gliomas Using RCAS/t-va Technology. , 2009, Translational oncology.
[30] O. Chinot,et al. Épendymomes intracrâniens de l'adulte. Analyse rétrospective de 121 cas provenant de l'étude multicentrique française , 2007 .
[31] S. Coons,et al. Is gross-total resection sufficient treatment for posterior fossa ependymomas? , 2002, Journal of neurosurgery.
[32] T. Merchant,et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] D. Ellison,et al. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] T. Merchant,et al. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] G. Reifenberger,et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. , 2008, The Journal of clinical investigation.
[36] P. Liberski,et al. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] R. Lai. Survival of patients with adult medulloblastoma , 2008, Cancer.
[38] T. Merchant,et al. Evolution of neurological impairment in pediatric infratentorial ependymoma patients , 2009, Journal of Neuro-Oncology.